Option Care Health (NASDAQ:OPCH – Get Free Report) had its target price lowered by stock analysts at JPMorgan Chase & Co. from $40.00 to $33.00 in a report released on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 56.10% from the company’s previous close.
OPCH has been the subject of a number of other research reports. Jefferies Financial Group reiterated a “buy” rating and set a $37.00 price objective on shares of Option Care Health in a research report on Tuesday, January 13th. Truist Financial set a $30.00 price objective on Option Care Health in a research report on Friday. Wall Street Zen cut Option Care Health from a “buy” rating to a “hold” rating in a research report on Saturday, February 28th. Citizens Jmp reiterated a “market outperform” rating and set a $38.00 price objective (up from $36.00) on shares of Option Care Health in a research report on Tuesday, January 13th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $26.00 price objective on shares of Option Care Health in a research report on Friday. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $32.08.
Read Our Latest Research Report on Option Care Health
Option Care Health Price Performance
Option Care Health (NASDAQ:OPCH – Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.03. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The business’s revenue for the quarter was up 1.3% compared to the same quarter last year. During the same quarter last year, the company earned $0.40 earnings per share. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. As a group, sell-side analysts predict that Option Care Health will post 1.69 earnings per share for the current year.
Institutional Trading of Option Care Health
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Cornerstone Investment Partners LLC grew its holdings in Option Care Health by 3.4% in the 4th quarter. Cornerstone Investment Partners LLC now owns 9,773 shares of the company’s stock valued at $311,000 after buying an additional 318 shares during the period. Sheets Smith Wealth Management grew its holdings in shares of Option Care Health by 1.3% during the 4th quarter. Sheets Smith Wealth Management now owns 26,167 shares of the company’s stock worth $834,000 after purchasing an additional 326 shares during the period. UMB Bank n.a. grew its holdings in shares of Option Care Health by 23.5% during the 4th quarter. UMB Bank n.a. now owns 1,715 shares of the company’s stock worth $55,000 after purchasing an additional 326 shares during the period. Fifth Third Bancorp grew its holdings in shares of Option Care Health by 21.9% during the 4th quarter. Fifth Third Bancorp now owns 2,328 shares of the company’s stock worth $74,000 after purchasing an additional 419 shares during the period. Finally, Andina Capital Management LLC grew its holdings in shares of Option Care Health by 2.6% during the 4th quarter. Andina Capital Management LLC now owns 16,320 shares of the company’s stock worth $520,000 after purchasing an additional 419 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.
About Option Care Health
Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.
Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.
Read More
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.
